286 related articles for article (PubMed ID: 17446333)
1. N-terminal pro-B-type natriuretic peptide predicts total and cardiovascular mortality in individuals with or without stable coronary artery disease: the Ludwigshafen Risk and Cardiovascular Health Study.
März W; Tiran B; Seelhorst U; Wellnitz B; Bauersachs J; Winkelmann BR; Boehm BO;
Clin Chem; 2007 Jun; 53(6):1075-83. PubMed ID: 17446333
[TBL] [Abstract][Full Text] [Related]
2. N-terminal pro-B-type natriuretic peptide and long-term mortality in stable coronary heart disease.
Kragelund C; Grønning B; Køber L; Hildebrandt P; Steffensen R
N Engl J Med; 2005 Feb; 352(7):666-75. PubMed ID: 15716560
[TBL] [Abstract][Full Text] [Related]
3. Relationship and prognostic importance of thyroid hormone and N-terminal pro-B-Type natriuretic peptide for patients after acute coronary syndromes: a longitudinal observational study.
Brozaitiene J; Mickuviene N; Podlipskyte A; Burkauskas J; Bunevicius R
BMC Cardiovasc Disord; 2016 Feb; 16():45. PubMed ID: 26892923
[TBL] [Abstract][Full Text] [Related]
4. Risk stratification in stable coronary artery disease is possible at cardiac troponin levels below conventional detection and is improved by use of N-terminal pro-B-type natriuretic peptide.
Lyngbæk S; Winkel P; Gøtze JP; Kastrup J; Gluud C; Kolmos HJ; Kjøller E; Jensen GB; Hansen JF; Hildebrandt P; Hilden J;
Eur J Prev Cardiol; 2014 Oct; 21(10):1275-84. PubMed ID: 23723326
[TBL] [Abstract][Full Text] [Related]
5. Prognostic value of B-Type natriuretic peptides in patients with stable coronary artery disease: the PEACE Trial.
Omland T; Sabatine MS; Jablonski KA; Rice MM; Hsia J; Wergeland R; Landaas S; Rouleau JL; Domanski MJ; Hall C; Pfeffer MA; Braunwald E;
J Am Coll Cardiol; 2007 Jul; 50(3):205-14. PubMed ID: 17631211
[TBL] [Abstract][Full Text] [Related]
6. N-terminal pro-B-type natriuretic peptide and B-type natriuretic peptide for identifying coronary artery disease and left ventricular hypertrophy in ambulatory chronic kidney disease patients.
Khan IA; Fink J; Nass C; Chen H; Christenson R; deFilippi CR
Am J Cardiol; 2006 May; 97(10):1530-4. PubMed ID: 16679099
[TBL] [Abstract][Full Text] [Related]
7. Role of B-Type Natriuretic Peptide and N-Terminal Prohormone BNP as Predictors of Cardiovascular Morbidity and Mortality in Patients With a Recent Coronary Event and Type 2 Diabetes Mellitus.
Wolsk E; Claggett B; Pfeffer MA; Diaz R; Dickstein K; Gerstein HC; Lawson FC; Lewis EF; Maggioni AP; McMurray JJV; Probstfield JL; Riddle MC; Solomon SD; Tardif JC; Køber L
J Am Heart Assoc; 2017 May; 6(6):. PubMed ID: 28554908
[TBL] [Abstract][Full Text] [Related]
8. Usefulness of N-terminal pro-B-type natriuretic peptide increase with exercise for predicting cardiovascular mortality in patients with heart failure.
Koç M; Bozkurt A; Acartürk E; Sahin DY; Unal I
Am J Cardiol; 2008 Apr; 101(8):1157-62. PubMed ID: 18394451
[TBL] [Abstract][Full Text] [Related]
9. Asymmetrical dimethylarginine independently predicts total and cardiovascular mortality in individuals with angiographic coronary artery disease (the Ludwigshafen Risk and Cardiovascular Health study).
Meinitzer A; Seelhorst U; Wellnitz B; Halwachs-Baumann G; Boehm BO; Winkelmann BR; März W
Clin Chem; 2007 Feb; 53(2):273-83. PubMed ID: 17185364
[TBL] [Abstract][Full Text] [Related]
10. Prognostic efficacy of cardiac biomarkers for mortality in dialysis patients.
Hickman PE; McGill DA; Talaulikar G; Hiremagalur B; Bromley J; Rahman A; Koerbin G; Southcott E; Potter JM
Intern Med J; 2009 Dec; 39(12):812-8. PubMed ID: 20233242
[TBL] [Abstract][Full Text] [Related]
11. Usefulness of repeated N-terminal pro-B-type natriuretic peptide measurements as incremental predictor for long-term cardiovascular outcome after vascular surgery.
Goei D; van Kuijk JP; Flu WJ; Hoeks SE; Chonchol M; Verhagen HJ; Bax JJ; Poldermans D
Am J Cardiol; 2011 Feb; 107(4):609-14. PubMed ID: 21185000
[TBL] [Abstract][Full Text] [Related]
12. Usefulness of serum N-terminal pro-brain natriuretic peptide to predict in-stent restenosis in patients with preserved left ventricular function and normal troponin I levels.
Hong SN; Ahn Y; Yoon NS; Lee KH; Kim YS; Hwang SH; Lee SR; Kim KH; Park HW; Hong YJ; Kim JH; Jeong MH; Cho JG; Park JC; Kang JC
Am J Cardiol; 2007 Apr; 99(8):1051-4. PubMed ID: 17437726
[TBL] [Abstract][Full Text] [Related]
13. N-terminal pro-brain natriuretic peptide: an independent risk predictor of cardiovascular congestion, mortality, and adverse cardiovascular outcomes in chronic peritoneal dialysis patients.
Wang AY; Lam CW; Yu CM; Wang M; Chan IH; Zhang Y; Lui SF; Sanderson JE
J Am Soc Nephrol; 2007 Jan; 18(1):321-30. PubMed ID: 17167121
[TBL] [Abstract][Full Text] [Related]
14. Plasma levels of N-terminal pro-brain natriuretic peptide in patients with coronary artery disease and relation to clinical presentation, angiographic severity, and left ventricular ejection fraction.
Ndrepepa G; Braun S; Mehilli J; von Beckerath N; Vogt W; Schömig A; Kastrati A
Am J Cardiol; 2005 Mar; 95(5):553-7. PubMed ID: 15721090
[TBL] [Abstract][Full Text] [Related]
15. N-terminal pro-brain-type natriuretic peptide (NT-pro-BNP) and mortality risk in early inflammatory polyarthritis: results from the Norfolk Arthritis Registry (NOAR).
Mirjafari H; Welsh P; Verstappen SM; Wilson P; Marshall T; Edlin H; Bunn D; Chipping J; Lunt M; Symmons DP; Sattar N; Bruce IN
Ann Rheum Dis; 2014 Apr; 73(4):684-90. PubMed ID: 23511225
[TBL] [Abstract][Full Text] [Related]
16. Troponin T and N-terminal pro B-Type natriuretic peptide and presence of coronary artery disease.
Mouridsen MR; Sajadieh A; Carlsen CM; Mattsson N; Heitmann M; Nielsen OW
Scand J Clin Lab Invest; 2015 May; 75(3):204-12. PubMed ID: 25629204
[TBL] [Abstract][Full Text] [Related]
17. Joint effects of N-terminal pro-B-type-natriuretic peptide and C-reactive protein vs angiographic severity in predicting major adverse cardiovascular events and clinical restenosis after coronary angioplasty in patients with stable coronary artery disease.
Dai DF; Hwang JJ; Lin JL; Lin JW; Hsu CN; Lin CM; Chiang FT; Lai LP; Hsu KL; Tseng CD; Tseng YZ
Circ J; 2008 Aug; 72(8):1316-23. PubMed ID: 18654020
[TBL] [Abstract][Full Text] [Related]
18. Accuracy of N-terminal pro-brain natriuretic peptide to predict mortality in various subsets of patients with coronary artery disease.
Ndrepepa G; Braun S; Schömig A; Kastrati A
Am J Cardiol; 2007 Aug; 100(4):575-8. PubMed ID: 17697808
[TBL] [Abstract][Full Text] [Related]
19. Relation of N-terminal pro-B-type natriuretic peptide to symptoms, severity, and left ventricular remodeling in patients with organic mitral regurgitation.
Potocki M; Mair J; Weber M; Hamm C; Burkard T; Hiemetzberger R; Peters K; Jander N; Cron TA; Hess N; Hoffmann A; Gekeler H; Gohlke-Bärwolf C; Buser P; Mueller C
Am J Cardiol; 2009 Aug; 104(4):559-64. PubMed ID: 19660612
[TBL] [Abstract][Full Text] [Related]
20. Effect Modification of Chronic Kidney Disease on the Association of Circulating and Imaging Cardiac Biomarkers With Outcomes.
Gregg LP; Adams-Huet B; Li X; Colbert G; Jain N; de Lemos JA; Hedayati SS
J Am Heart Assoc; 2017 Jul; 6(7):. PubMed ID: 28679558
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
